Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cory R Trankle

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Pacing and Clinical Electrophysiology : PACE|November 30, 2022
Impact of transcatheter mitral valve edge-to-edge repair on atrial fibrillation burden: Insights from a multicenter cohortCory R Trankle, Patricia F Rodriguez Lozano, Paul D Mahoney, et al.
Health Science Reports|November 29, 2023
Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta-analysisDhan B Shrestha, Sagun Dawadi, Bishal Dhakal, et al.
Journal of the American College of Cardiology|December 3, 2016
Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection FractionSalvatore Carbone, Justin M Canada, Leo F Buckley, et al.
Journal of Cardiovascular Pharmacology|June 16, 2021
Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF StudyDave L Dixon, Hayley E Billingsley, Justin M Canada, et al.
Journal of Cardiovascular Pharmacology|July 30, 2019
Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT)Cory R Trankle, George Wohlford, Leo F Buckley, et al.
Journal of Cardiovascular Pharmacology|July 5, 2021
Sacubitril/Valsartan for the Prevention and Treatment of Postinfarction Heart Failure: Ready to Use?Marco G Del Buono, Juan I Damonte, Cory R Trankle, et al.
Cardio-Oncology (London, England)|March 11, 2020
Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathyJustin M Canada, Georgia K Thomas, Cory R Trankle, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2018
IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot StudyCory R Trankle, Justin M Canada, Dinesh Kadariya, et al.
Lung|July 9, 2021
Diastolic Dysfunction Contributes to Impaired Cardiorespiratory Fitness in Patients with Lung Cancer and Reduced Lung Function Following Chest RadiationGeorgia K Thomas, Cory R Trankle, Salvatore Carbone, et al.
ESC Heart Failure|January 19, 2018
Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fractionLeo F Buckley, Justin M Canada, Marco G Del Buono, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Pacing and Clinical Electrophysiology : PACE|November 30, 2022
Impact of transcatheter mitral valve edge-to-edge repair on atrial fibrillation burden: Insights from a multicenter cohortCory R Trankle, Patricia F Rodriguez Lozano, Paul D Mahoney, et al.
Health Science Reports|November 29, 2023
Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta-analysisDhan B Shrestha, Sagun Dawadi, Bishal Dhakal, et al.
Journal of the American College of Cardiology|December 3, 2016
Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection FractionSalvatore Carbone, Justin M Canada, Leo F Buckley, et al.
Journal of Cardiovascular Pharmacology|June 16, 2021
Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF StudyDave L Dixon, Hayley E Billingsley, Justin M Canada, et al.
Journal of Cardiovascular Pharmacology|July 30, 2019
Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT)Cory R Trankle, George Wohlford, Leo F Buckley, et al.
Journal of Cardiovascular Pharmacology|July 5, 2021
Sacubitril/Valsartan for the Prevention and Treatment of Postinfarction Heart Failure: Ready to Use?Marco G Del Buono, Juan I Damonte, Cory R Trankle, et al.
Cardio-Oncology (London, England)|March 11, 2020
Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathyJustin M Canada, Georgia K Thomas, Cory R Trankle, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2018
IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot StudyCory R Trankle, Justin M Canada, Dinesh Kadariya, et al.
Lung|July 9, 2021
Diastolic Dysfunction Contributes to Impaired Cardiorespiratory Fitness in Patients with Lung Cancer and Reduced Lung Function Following Chest RadiationGeorgia K Thomas, Cory R Trankle, Salvatore Carbone, et al.
ESC Heart Failure|January 19, 2018
Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fractionLeo F Buckley, Justin M Canada, Marco G Del Buono, et al.
Pageof 8